Jenna Burton

Faculty Clinical Sciences

ACC216 Flint Cancer Center

About Jenna

Dr. Burton is an Assistant Professor of Medical Oncology and coordinator of the CSU Flint Animal Cancer Center clinical trials program, which has more than 30 active clinical trials enrolling over 250 dogs and cats annually. Her research interests include evaluation of novel cancer therapies in spontaneously occurring animal models through clinical trials as well as investigating benefits and barriers to veterinary clinical trial participation. She is a PI for several studies organized by the NCI Comparative Oncology Trials Consortia (COTC), a network of comparative oncology centers that functions to design and performs clinical trials in pet dogs with cancer to assess novel treatments.

Education

MS, Colorado State University, 2011DVM, The Ohio State University, 2006BA, Bowdoin College, 1994

Certifications

Diplomate - American College of Veterinary Internal Medicine (Oncology)

Publications

Biller BJ, Guth A, Burton JH, Dow S: Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma. Journal of Veterinary Internal Medicine 24(5):1118-1123, 2010. Burton JH, Mitchell L, Thamm DH, Dow SW, Biller BJ: Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma. Journal of Veterinary Internal Medicine 25(4):920-926, 2011.Burton JH, Garrett-Mayer E, Thamm DH: Evaluation of a 15 week CHOP Protocol for the Treatment of Canine Multicentric Lymphoma. Veterinary and Comparative Oncology, 2012 (Epub ahead of print).Burton JH, Powers BE, Biller BJ: Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996– 2011. Veterinary and Comparative Oncology, 2012 (Epub ahead of print).Forster GM, Ollila CA, Burton JH, Hill D, Bauer JE, Hess AM, Ryan EP: Nutritional Weight Loss Therapy with Cooked Bean Powders Regulates Serum Lipids and Biochemical Analytes in Overweight and Obese Dogs. Manuscript accepted for publication. Journal of Obesity and Weight Loss Therapy, 2012.Robat C, Burton JH, Thamm DH,Vail DM: Retrospective evaluation of doxorubicin/piroxicam combination for the treatment of transitional cell carcinoma in dogs. Manuscript accepted for publication. Journal of Small Animal Practice, 2012.

Research Specialty

Small Animal Exclusive

                

stdClass Object ( [GetMemberByIdResult] => stdClass Object ( [AddressPrivacy] => 1 [BusinessAddress1] => Veterinary Teaching Hospital - 300 W Drake Rd [BusinessAddress2] => Animal Cancer Center - ACC 218 [BusinessCity] => Fort Collins [BusinessPostalCode] => 80523 [BusinessState] => CO [CSUId] => 0 [DepartmentGroup] => Clinical Sciences Department [DirectoryPrivacy] => 1 [EName] => jhburton [EmailAddress] => Jenna.Burton@colostate.edu [EmailPrivacy] => 1 [EmployeeCategory] => Faculty [EmployeeTitle] => Faculty [EmployeeType] => Faculty [FirstName] => Jenna [GraduationYear] => [HasMemberCV] => [Id] => 1189 [InternalTitle] => Faculty [LastName] => Burton [MemberContacts] => stdClass Object ( ) [MemberDirectoryProfile] => stdClass Object ( [Id] => 374 [ProfileMetaData] => [ProfileText] => Dr. Burton is an Assistant Professor of Medical Oncology and coordinator of the CSU Flint Animal Cancer Center clinical trials program, which has more than 30 active clinical trials enrolling over 250 dogs and cats annually. Her research interests include evaluation of novel cancer therapies in spontaneously occurring animal models through clinical trials as well as investigating benefits and barriers to veterinary clinical trial participation. She is a PI for several studies organized by the NCI Comparative Oncology Trials Consortia (COTC), a network of comparative oncology centers that functions to design and performs clinical trials in pet dogs with cancer to assess novel treatments. ) [MiddleName] => Hart [NamePrivacy] => 1 [OfficeBldgName] => Flint Cancer Center [OfficeRoomName] => ACC216 [OtherName] => Jenna [PhonePrivacy] => 1 [StudentLevel] => [Website] => ) )